Skip to main content

Table 4 Prevalence and levels of antibodies to the OR domain of the P. falciparum P126 protein in Candeias do Jamari and Peixoto de Azevedo groups according to the infection patterns.

From: Evaluation of the genetic polymorphism of Plasmodium falciparum P126 protein (SERA or SERP) and its influence on naturally acquired specific antibody responses in malaria-infected individuals living in the Brazilian Amazon

Infection IgG IgM IgG1 IgG2 IgG3 IgG4
  Candeias do Jamari (CJ)
OR-II       
   CJ-1993 47/69 (68)
4.9 ± 3.0d
39/63 (62)
3.4 ± 2.1
39/44a(88)
3.2 ± 2.1e
6/44b(13)
3.1 ± 2.9
42/44c(95)
10.6 ± 10.0
19/44 (43)
1.6 ± 0.7f
   CJ-2002 55/70 (78)
8.4 ± 8.2j
57/70g (81)
4.8 ± 4.8
13/55h (23)
1.9 ± 0.7
19/55i(34)
1.3 ± 0.4
35/55 (60)
7.5 ± 6.1
23/55 (42)
2.6 ± 2.2k
  Peixoto de Azevedo (PA)
OR-I 19/25 (76)
4.9 ± 2.9
13/25 (52)
1.7 ± 0.9
13/18l (72)
2.0 ± 1.8
0/18m
-
18/18n (100)
9.8 ± 6.8
9/18 (50)
1.4 ± 0.2
OR-II 36/46 (78)
4.3 ± 2.7
27/46 (59)
2.7 ± 1.7
21/36o (58)
2.1 ± 1.7
5/36p (14)
1.3 ± 0.4
34/36q (94)
7.6 ± 6.1
16/36 (44)
1.3 ± 0.1
Mixed 16/19 (84)
4.5 ± 3.1
9/19 (47)
2.0 ± 1.4
11/16r(69)
2.9 ± 2.7
0/16s
-
16/16 (100)t
7.5 ± 6.4
5/16 (31)
1.3 ± 0.1
  1. The data represent the number of responders/total of each fragment tested (the percentage of responders is given in parentheses) and the antibody levels expressed as mean of OD index ± SD. P < 0.05. a: CJ-1993- IgG1 > IgG2, IgG1 > IgG4; CJ-1993 IgG1 > CJ-2002 IgG1; b: CJ-1993- IgG2 < IgG3, IgG2 < IgG4; CJ-1993 IgG2 < CJ-2002 IgG2; c: CJ-1993- IgG3 > IgG4; CJ-1993 IgG3 > CJ-2002 IgG3; d: CJ-1993 IgG < CJ-2002 IgG; e: CJ-1993 IgG1 > CJ-2002 IgG1; f: CJ-1993 IgG4 < CJ-2002 IgG4; g: CJ-2002 IgM > CJ-1993 IgM, CJ-2002 IgM > PA IgM; h: CJ-2002 IgG1 < IgG3; i: CJ-2002 IgG2 < IgG3; CJ-2002 IgG2 > PA OR-II IgG2; j: CJ-2002 IgG > PA OR-II IgG; k: CJ-2002 IgG4 > PA OR-II IgG4 l: PA OR-I IgG1 > IgG2; PA OR-I IgG1 < IgG3; m: PA OR-I IgG2 < IgG3; PA OR-I IgG2 < IgG4; n: PA OR-I IgG3 > IgG4; o: PA OR-II IgG1 > IgG2; PA OR-II IgG1 < IgG3; p: PA OR-II IgG2 < IgG3; PA OR-II IgG2 < IgG4; q: PA OR-II IgG3 > IgG4; CJ-2002 IgG3 < PA OR-II IgG3; r: PA mixed IgG1 > IgG2; s: PA mixed IgG2 > IgG3; t: PA mixed IgG3 > IgG4. The Student's t-test was used to analyse the differences in mean values, the Chi-square test was used to analyse the difference in prevalence of positive responses.